ASKA Pharmaceutical Holdings Co (TSE:4886) Beta: 0.2610 (As of Jul. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4886 ASKA Pharmaceutical Holdings Co Ltd TSE:4886
61 GF Score
Price 円2,244.00
GF Value 円2,402.52
Valuation Fairly Valued
View Full Analysis

What is ASKA Pharmaceutical Holdings Co Beta?

ASKA Pharmaceutical Holdings Co TSE:4886 +1.40% 61 Beta is 0.2610 as of Jul. 20, 2026. GuruFocus rates TSE:4886 with a GF Score™ of 61/100 and a GF Value™ of 円2,402.52 (Fairly Valued).

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-20), ASKA Pharmaceutical Holdings Co's Beta is 0.2610.


ASKA Pharmaceutical Holdings Co  (TSE:4886) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


ASKA Pharmaceutical Holdings Co Beta Related Terms


ASKA Pharmaceutical Holdings Co Beta Historical Data

* Premium members only.

The historical data trend for ASKA Pharmaceutical Holdings Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASKA Pharmaceutical Holdings Co Beta Chart

ASKA Pharmaceutical Holdings Co Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Beta
0.00 0.00 0.68 0.48 0.17

ASKA Pharmaceutical Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.44 0.29 0.04 0.17

TSE:4886 vs ZTS, UTHR: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ASKA Pharmaceutical Holdings Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ASKA Pharmaceutical Holdings Co Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ASKA Pharmaceutical Holdings Co's Beta distribution charts can be found below:

* The bar in red indicates where ASKA Pharmaceutical Holdings Co's Beta falls into.


TSE:4886
61GF Score
ASKA Pharmaceutical Holdings Co Ltd TSE:4886
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ASKA Pharmaceutical Holdings Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.2610 mean?
ASKA Pharmaceutical Holdings Co (TSE:4886) has a Beta of 0.2610 as of Jul. 20, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for ASKA Pharmaceutical Holdings Co and its competitors.
Is ASKA Pharmaceutical Holdings Co's Beta too high?
ASKA Pharmaceutical Holdings Co's current Beta is 0.2610. Overall, ASKA Pharmaceutical Holdings Co has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ASKA Pharmaceutical Holdings Co's Beta compare to ZTS and UTHR?
ASKA Pharmaceutical Holdings Co's Beta of 0.2610 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for ASKA Pharmaceutical Holdings Co and its competitors. ASKA Pharmaceutical Holdings Co's current Beta is 0.2610. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASKA Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co (TSE:4886) is currently considered Fairly Valued. The stock's GF Value™ is 円2,402.52, compared to a current price of 円2,244.00 — trading 6.6% below its estimated fair value. The current Beta is 0.2610. ASKA Pharmaceutical Holdings Co's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For ASKA Pharmaceutical Holdings Co (TSE:4886), the current Beta is 0.2610 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ASKA Pharmaceutical Holdings Co (TSE:4886) Overvalued in 2026?

Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co stock appears to be undervalued. The current stock price of 円2,244.00 is trading 6.6% below its estimated GF Value™ of 円2,402.52. GuruFocus considers ASKA Pharmaceutical Holdings Co to be Fairly Valued.

Key valuation signals for TSE:4886:

  • Beta: 0.2610
  • GF Value™: 円2,402.52 vs. price of 円2,244.00 (6.6% below fair value)
  • GF Score™: 61/100

No single metric tells the full story. See the TSE:4886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ASKA Pharmaceutical Holdings Co Business Description

Address 2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and other related operations.
61GF Score

Get the complete analysis for TSE:4886

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,244.00
Price
円2,402.52
GF Value